Friday, November 30, 2012

Aspirin can cut liver cancers and deaths study finds

Aspirin can reduce the risk of developing liver cancer or dying from chronic liver disease by around 50 per cent even if only taken monthly, a study has suggested

By Rebecca Smith | The Telegraph – 18 hours ago
People who said they had taken aspirin at least once a month in the past year were 49 per cent less likely to develop the most common for of liver cancer and 50 per cent less likely to die from chronic liver disease in the next ten years when compared with people who did not take the painkiller.

Aspirin has been hailed as a wonder drug after several studies have now found that it can significantly reduce the risk of cancer developing as well as cutting the chances of a heart attack and stroke.
 Taking a daily aspirin may prevent series diseases such as liver cancer

Wednesday, November 28, 2012


Grapefruits can trigger overdoses in dozens of medicines researchers warn

Millions of people taking medicines for high cholesterol, cancer and to prevent heart attacks are at risk of potentially life threatening side effects if they eat grapefruits, doctors have warned.

By Rebecca Smith | The Telegraph – 23 hours ago

A study has listed 43 major drugs which are affected by eating grapefruits or drinking the juice and experts have warned there needs to be more awareness of the risks.

The number of drugs that interact with grapefruit increased from 17 in 2000 to 43 in 2008, researchers in Canada found.

Eating one grapefruit a day or drinking 200ml of juice was enough to trigger significant side effects in some of the patients.

Elderly patients were at particular risk because they are more likely to eat grapefruit and be on the medicines that interact with it, while their bodies are less able to cope with the effects of an overdose, the researchers said.

Wednesday, November 14, 2012


British medical journal slams Roche on Tamiflu

LONDON (AP) — A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.

The drug has been stockpiled by dozens of governments worldwide in case of a global flu outbreak and was widely used during the 2009 swine flu pandemic.

On Monday, one of the researchers linked to the BMJ journal called for European governments to sue Roche.

"I suggest we boycott Roche's products until they publish missing Tamiflu data," wrote Peter Gotzsche, leader of the Nordic Cochrane Centre in Copenhagen. He said governments should take legal action against Roche to get the money back that was "needlessly" spent on stockpiling Tamiflu.

Last year, Tamiflu was included in a list of "essential medicines" by the World Health Organization, a list that often prompts governments or donor agencies to buy the drug.

Tamiflu is used to treat both seasonal flu and new flu viruses like bird flu or swine flu. WHO spokesman Gregory Hartl said the agency had enough proof to warrant its use for unusual influenza viruses, like bird flu.

"We do have substantive evidence it can stop or hinder progression to severe disease like pneumonia," he said.

In the U.S., the Centers for Disease Control and Prevention recommends Tamiflu as one of two medications for treating regular flu. The other is GlaxoSmithKline's Relenza. The CDC says such antivirals can shorten the duration of symptoms and reduce the risk of complications and hospitalization.

In 2009, the BMJ and researchers at the Nordic Cochrane Centre asked Roche to make all its Tamiflu data available. At the time, Cochrane Centre scientists were commissioned by Britain to evaluate flu drugs. They found no proof that Tamiflu reduced the number of complications in people with influenza.

"Despite a public promise to release (internal company reports) for each (Tamiflu) trial...Roche has stonewalled," BMJ editor Fiona Godlee wrote in an editorial last month.

In a statement, Roche said it had complied with all legal requirements on publishing data and provided Gotzsche and his colleagues with 3,200 pages of information to answer their questions.
"Roche has made full clinical study data ... available to national health authorities according to their various requirements, so they can conduct their own analyses," the company said.

Roche says it doesn't usually release patient-level data available due to legal or confidentiality constraints. It said it did not provide the requested data to the scientists because they refused to sign a confidentiality agreement.

Roche is also being investigated by the European Medicines Agency for not properly reporting side effects, including possible deaths, for 19 drugs including Tamiflu that were used in about 80,000 patients in the U.S.


Sunday, November 11, 2012

Greetings of the new day. The morning is always an opportunity to start all over again if we must, it is God's way of telling us that our job on earth is still remaining, therefore we should place enough weight-able emphasis on the morning. Then morning meal which is usually called Breakfast is about the most important meal of the day because it helps to stabilize our blood sugar thus giving us the impetus we need to tread through the day. Make it a duty to take a breakfast every day - a good combination of carbohydrate, protein, and minerals would do. Find that combination Have a good day today Dr. Jerry - the First Oguzie

Saturday, November 10, 2012

Welcome Message

Welcome to our blog and thank you for being there. As the title suggests, we intend to share with you tips for healthy living and also news on health. It is our belief that you would be richly blessed for belonging here. feel free to connect with us and also contact us at any time Dr. Jerry - the First Oguzie